1. Home
  2. UIS vs SGMO Comparison

UIS vs SGMO Comparison

Compare UIS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$2.08

Market Cap

164.7M

Sector

Technology

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
SGMO
Founded
1942
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.7M
141.2M
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
UIS
SGMO
Price
$2.08
$0.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$5.67
$7.00
AVG Volume (30 Days)
536.2K
6.5M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.20
EPS
N/A
N/A
Revenue
$1,950,100,000.00
$36,567,000.00
Revenue This Year
N/A
$24.46
Revenue Next Year
$2.60
$193.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
88.60
52 Week Low
$2.00
$0.21
52 Week High
$5.33
$0.84

Technical Indicators

Market Signals
Indicator
UIS
SGMO
Relative Strength Index (RSI) 36.87 33.54
Support Level N/A N/A
Resistance Level $2.65 $0.55
Average True Range (ATR) 0.08 0.04
MACD -0.00 -0.01
Stochastic Oscillator 25.40 22.71

Price Performance

Historical Comparison
UIS
SGMO

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: